GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ginkgo Bioworks Holdings Inc (OTCPK:DNABW) » Definitions » Debt-to-Revenue

DNABW (Ginkgo Bioworks Holdings) Debt-to-Revenue : 2.01 (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Ginkgo Bioworks Holdings Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Ginkgo Bioworks Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was $0.00 Mil. Ginkgo Bioworks Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was $452.27 Mil. Ginkgo Bioworks Holdings's annualized Revenue for the quarter that ended in Jun. 2024 was $224.82 Mil. Ginkgo Bioworks Holdings's annualized Debt-to-Revenue for the quarter that ended in Jun. 2024 was 2.01.


Ginkgo Bioworks Holdings Debt-to-Revenue Historical Data

The historical data trend for Ginkgo Bioworks Holdings's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ginkgo Bioworks Holdings Debt-to-Revenue Chart

Ginkgo Bioworks Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
- 0.22 0.07 0.93 0.96

Ginkgo Bioworks Holdings Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.28 1.82 1.74 1.55 2.01

Competitive Comparison of Ginkgo Bioworks Holdings's Debt-to-Revenue

For the Biotechnology subindustry, Ginkgo Bioworks Holdings's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ginkgo Bioworks Holdings's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ginkgo Bioworks Holdings's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Ginkgo Bioworks Holdings's Debt-to-Revenue falls into.



Ginkgo Bioworks Holdings Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Ginkgo Bioworks Holdings's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(19.933 + 221.835) / 251.455
=0.96

Ginkgo Bioworks Holdings's annualized Debt-to-Revenue for the quarter that ended in Jun. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0 + 452.265) / 224.824
=2.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Jun. 2024) Revenue data.


Ginkgo Bioworks Holdings Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Ginkgo Bioworks Holdings's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Ginkgo Bioworks Holdings Business Description

Traded in Other Exchanges
Address
27 Drydock Avenue, 8th Floor, Boston, MA, USA, 02210
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.